Page 106 - CPG มะเร็งปากมดลูก
P. 106
100 แนวทางการป?องกันและรกั ษามะเรง็ ปากมดลกู
เอกสารอ?างอิง
1. Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework
for neuroendocrine neoplasms: an International Agency for Research on Cancer ( IARC) and World Health
Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31:1770-86.
2. Howitt BE, Kelly P, McCluggage WG. Pathology of Neuroendocrine Tumours of the Female Genital Tract. Curr
Oncol Rep. 2017;19:59.
3. Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and prognostic factors of small cell carcinoma of the
cervix. Obstet Gynecol. 2008;111:1394-402.
4. Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic
Oncology (SGO) clinical document. Gynecol Oncol. 2011;122:190-8.
5. Tempfer CB, Tischoff I, Dogan A, Hilal Z, Schultheis B, Kern P, et al. Neuroendocrine carcinoma of the cervix: a
systematic review of the literature. BMC Cancer. 2018;18:530.
6. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, et al. Small cell carcinoma of the cervix: treatment
and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010;203:347.e1-6.
7. Castle PE, Pierz A, Stoler MH. A systematic review and meta-analysis on the attribution of human papillomavirus
(HPV) in neuroendocrine cancers of the cervix. Gynecol Oncol. 2018;148:422-9.
8. Inzani F, Santoro A, Angelico G, Feraco A, Spadola S, Arciuolo D, et al. Neuroendocrine Carcinoma of the Uterine
Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2-Sst5). Cancers
(Basel). 2020;12.
9. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet.
2021;155 Suppl 1:28-44.
10. McCusker ME, Cot? TR, Clegg LX, Tavassoli FJ. Endocrine tumors of the uterine cervix: incidence, demographics,
and survival with comparison to squamous cell carcinoma. Gynecol Oncol. 2003;88:333-9.
11. Gordhandas S, Schlappe BA, Zhou Q, Iasonos A, Leitao MM, Jr. , Park KJ, et al. Small cell neuroendocrine
carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis. Gynecol Oncol Rep.
2022;43:101058.
12. Cervical Cancer: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?); 2024 [updated September 20,
2023. Version 1.2024
13. Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ. Small cell neuroendocrine carcinoma
of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004;93:27-33.
14. Hoskins PJ, Swenerton KD, Pike JA, Lim P, Aquino-Parsons C, Wong F, et al. Small-cell carcinoma of the cervix:
fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation
and platinum-based combination chemotherapy. J Clin Oncol. 2003;21:3495-501.
15. Gadducci A, Carinelli S, Aletti G. Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for
gynecologic oncologists. Gynecol Oncol. 2017;144:637-46.
16. Lee JM, Lee KB, Nam JH, Ryu SY, Bae DS, Park JT, et al. Prognostic factors in FIGO stage IB-IIA small cell
neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean
study. Ann Oncol. 2008;19:321-6.
17. Boruta DM, 2nd, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Multimodality therapy in early-stage
neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol. 2001;81:82-7.
18. Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH. Prognostic factors in surgically treated small cell
cervical carcinoma followed by adjuvant chemotherapy. Cancer. 1998;83:712-8.
